Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             49 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormalities of theP16 INK4A gene in thyroid cancer cell lines Ivan, M.
 1996
 32 13 p. 2369-2370
2 p.
 artikel
2 Analysis of O 6-methylguanine-DNA methyltransferase mRNA in fine needle biopsies from human melanoma metastases by reverse transcription and polymerase chain reaction Hansson, J.
 1996
 32 13 p. 2319-2326
8 p.
 artikel
3 A Phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinoma Raderer, M.
 1996
 32 13 p. 2366-2368
3 p.
 artikel
4 A Pilot study to evaluate paclitaxel (Taxol™) as primary medical treatment for patients with inoperable stage III and IV breast carcinoma Rees, C.N.
 1996
 32 13 p. 2354-2356
3 p.
 artikel
5 Breast cancer Mortality in MalmMö 1996
 32 13 p. 2191-
1 p.
 artikel
6 Breast cancer prevention trial needs 3000 fewer women than planned 1996
 32 13 p. 2188-
1 p.
 artikel
7 Calendar of forthcoming meeting 1996
 32 13 p. I-III
nvt p.
 artikel
8 Chemotherapy of high-grade gliomas: Beginning of a new era or the end of the old? Brada, M.
 1996
 32 13 p. 2193-2194
2 p.
 artikel
9 Cisplatin combined with the new cisplatin-procaine complex dpr: In vitro and in vivo studies Viale, M.
 1996
 32 13 p. 2327-2333
7 p.
 artikel
10 Complications of an implantable venous access device (Port-a-Cath®) during intermittent continuous infusion of chemotherapy Poorter, R.L.
 1996
 32 13 p. 2262-2266
5 p.
 artikel
11 Congress accept national cancer institute budget proposal: New Ventures can go ahead 1996
 32 13 p. 2187-
1 p.
 artikel
12 Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas Hagel, C.
 1996
 32 13 p. 2242-2248
7 p.
 artikel
13 Elevated germ cell markers in carcinoma of uncertain primary site do not predict response to platinum based chemotherapy Currow, D.C.
 1996
 32 13 p. 2357-2359
3 p.
 artikel
14 Enhanced invasiveness of tumour cells after host exposure to heavy metals Haga, A.
 1996
 32 13 p. 2342-2347
6 p.
 artikel
15 Etoposide for the treatment of paediatric tumours: What is the best way to give it? Lowis, S.P.
 1996
 32 13 p. 2291-2297
7 p.
 artikel
16 European commision to remove obstacles to research, teaching and training abroad 1996
 32 13 p. 2189-
1 p.
 artikel
17 Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry Brotherick, I.
 1996
 32 13 p. 2334-2341
8 p.
 artikel
18 Fertiliser Nitrate in water increases non-Hodgkin Lymphoma 1996
 32 13 p. 2187-2188
2 p.
 artikel
19 First Nationwide survey on Nasopharyngeal carcinoma in Finland 1996
 32 13 p. 2190-
1 p.
 artikel
20 Hodgkin's Disease cure should be 100% 1996
 32 13 p. 2189-
1 p.
 artikel
21 IARC fellowships for research training in cancer 1997–1998 1996
 32 13 p. 2188-
1 p.
 artikel
22 Inheritance and susceptibility to tumours of the large bowel: A new classification of colorectal malignancies de Leon, M.Ponz
 1996
 32 13 p. 2206-2211
6 p.
 artikel
23 Intra-epithelial and invasive cervical neoplasia during HIV infection Boccalon, M.
 1996
 32 13 p. 2212-2217
6 p.
 artikel
24 Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? Cohen, A.M.
 1996
 32 13 p. 2195-2197
3 p.
 artikel
25 Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? Köhne, C.-H.
 1996
 32 13 p. 2197-2201
5 p.
 artikel
26 Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? de Takats, P.G.
 1996
 32 13 p. 2201-2205
5 p.
 artikel
27 Lack of carboplatin activity in malignant lymphomas Balzarotti, M.
 1996
 32 13 p. 2370-2371
2 p.
 artikel
28 Letters to the editor: Comments on Prebiopsy neoadjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression, oliver et al., Eurj cancer, 32A, No. 3, pp. 396–397, 1996 Oliver, R.T.D.
 1996
 32 13 p. 2365-2366
2 p.
 artikel
29 Letters to the editor: Comments on Prebiopsy neoadjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression, oliver et al., EurJ cancer, 32A, No. 3, pp. 396–397, 1996 Mokbel, K.
 1996
 32 13 p. 2364-
1 p.
 artikel
30 Men at higher sun-risk than women: Health message needs to be made 1996
 32 13 p. 2190-
1 p.
 artikel
31 Mixing anthracyclines and radiotherapy in early breast cancer: How Safe is it? HjiYiannakis, P.
 1996
 32 13 p. 2374-2377
4 p.
 artikel
32 Motality rates from oral cancers not all explained by alcohol and tabacco 1996
 32 13 p. 2190-
1 p.
 artikel
33 Oestrogen and progesterone receptors in gastrointestinal cancer cell lines Jacobs, E.
 1996
 32 13 p. 2348-2353
6 p.
 artikel
34 Polymorphisms in P21 CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours Milner, B.J.
 1996
 32 13 p. 2360-2363
4 p.
 artikel
35 Primary gastric non-Hodgkin's lymphoma stage IE and IIE Lybeert, M.L.M.
 1996
 32 13 p. 2306-2311
6 p.
 artikel
36 Quality of life: Perception of lung cancer patients Montazeri, A.
 1996
 32 13 p. 2284-2289
6 p.
 artikel
37 Radon exposure and incidence of paediatric malignancies Thorne, R.
 1996
 32 13 p. 2371-2372
2 p.
 artikel
38 Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115 000 screened infants in Austria Kerbl, R.
 1996
 32 13 p. 2298-2305
8 p.
 artikel
39 Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients Ferrari, G.
 1996
 32 13 p. 2368-2369
2 p.
 artikel
40 Sixth Charles Heidelberger Conference on “control of cell proliferation and differentiation: molecular targets in carcinogenesis and cancer therapy”, 9–13 July 1995, Essen, Germany Rajewsky, M.F.
 1996
 32 13 p. 2218-2228
11 p.
 artikel
41 Surveillance versus adjuvant chemotherapy in stage I non-seminomatous testicular cancer: A decision analysis Stiggelbout, A.M.
 1996
 32 13 p. 2267-2274
8 p.
 artikel
42 The charing cross hospital experience with temozolomide in patients with gliomas Newlands, E.S.
 1996
 32 13 p. 2236-2241
6 p.
 artikel
43 The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments Walker, L.G.
 1996
 32 13 p. 2275-2283
9 p.
 artikel
44 The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer Evans, W.K.
 1996
 32 13 p. 2249-2255
7 p.
 artikel
45 Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study Sanson, M.
 1996
 32 13 p. 2229-2235
7 p.
 artikel
46 Tumour necrosis factor and interferon are selectively cytostatic in vitro for hormone-dependent and hormone-independent human breast cancer cells Mueller, H.
 1996
 32 13 p. 2312-2318
7 p.
 artikel
47 Unknown primary carcinoma: Randomised studies are needed to identify optimal treatments and their benefits Farrugia, D.C.
 1996
 32 13 p. 2256-2261
6 p.
 artikel
48 Very high male lung cancer incidence in areas with tobacco industries Janssen-Heijnen, M.L.G.
 1996
 32 13 p. 2372-2373
2 p.
 artikel
49 Women smokers at higher risk of lung cancer that males 1996
 32 13 p. 2191-
1 p.
 artikel
                             49 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland